CWGCX
Price
$67.06
Change
-$0.16 (-0.24%)
Updated
Sep 20 closing price
FTGQX
Price
$27.04
Change
-$0.11 (-0.41%)
Updated
Sep 20 closing price
Ad is loading...

CWGCX vs FTGQX

Header iconCWGCX vs FTGQX Comparison
Open Charts CWGCX vs FTGQXBanner chart's image
American Funds Capital World Gr&Inc C
Price$67.06
Change-$0.16 (-0.24%)
VolumeN/A
CapitalizationN/A
Templeton Growth C
Price$27.04
Change-$0.11 (-0.41%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CWGCX vs FTGQX Comparison Chart
Loading...
VS
CWGCX vs. FTGQX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGCX is a StrongBuy and FTGQX is a StrongBuy.

FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 128B vs. FTGQX (8.78B). CWGCX pays higher dividends than FTGQX: CWGCX (1.04) vs FTGQX (0.76). CWGCX was incepted earlier than FTGQX: CWGCX (24 years) vs FTGQX (6 years). FTGQX is a more actively managed with annual turnover of: 33.07 vs. CWGCX (27.00). CWGCX has a lower initial minimum investment than FTGQX: CWGCX (250) vs FTGQX (1000). CWGCX annual gain was more profitable for investors over the last year : 19.12 vs. FTGQX (15.03). CWGCX return over 5 years is better than : 40.68 vs. FTGQX (26.35).
CWGCXFTGQXCWGCX / FTGQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years6 years-
Gain YTD11.8566.934171%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets128B8.78B1,457%
Annual Yield % from dividends1.040.76138%
Returns for 1 year19.1215.03127%
Returns for 3 years4.4111.4838%
Returns for 5 years40.6826.35154%
Returns for 10 years45.01N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNFT4.340.11
+2.60%
Genfit SA
CCL18.360.33
+1.83%
Carnival Corp
IMNM15.500.10
+0.65%
Immunome
PGNY24.44-0.38
-1.53%
Progyny
MTNB3.52-0.07
-2.00%
Matinas Biopharma Holdings Inc